PubRank

Johan Kuiper

Author PubWeight™ 65.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003 3.70
2 Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 2007 2.21
3 HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005 1.70
4 HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005 1.66
5 Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003 1.62
6 The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010 1.55
7 Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovasc Res 2012 1.49
8 Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J 2013 1.48
9 Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice. Atherosclerosis 2011 1.42
10 Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood 2007 1.27
11 Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ Res 2007 1.27
12 The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 2009 1.24
13 Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2006 1.21
14 Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc Res 2009 1.16
15 Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 2002 1.16
16 CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007 1.11
17 Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med 2011 1.10
18 Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J Lipid Res 2009 1.07
19 Total body ABCG1 expression protects against early atherosclerotic lesion development in mice. Arterioscler Thromb Vasc Biol 2007 1.05
20 Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol 2007 1.03
21 KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arterioscler Thromb Vasc Biol 2006 1.01
22 Scavenger receptors: friend or foe in atherosclerosis? Curr Opin Lipidol 2005 1.00
23 Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J Lipid Res 2013 0.96
24 Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. Circ Res 2013 0.95
25 P-selectin as a candidate target in atherosclerosis. Biochem Pharmacol 2003 0.95
26 Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Arterioscler Thromb Vasc Biol 2013 0.94
27 Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2010 0.93
28 Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Arterioscler Thromb Vasc Biol 2005 0.93
29 Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler Thromb Vasc Biol 2010 0.92
30 Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J 2012 0.91
31 Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J Nutr Biochem 2011 0.89
32 Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. Circ Res 2003 0.89
33 Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol 2013 0.88
34 Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb Haemost 2009 0.88
35 Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res 2006 0.87
36 Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Cardiovasc Res 2013 0.87
37 T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arterioscler Thromb Vasc Biol 2013 0.87
38 Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists. Blood 2002 0.86
39 Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2007 0.86
40 Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice. Cardiovasc Res 2008 0.84
41 Vaccination against TIE2 reduces atherosclerosis. Atherosclerosis 2008 0.83
42 Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration. Arterioscler Thromb Vasc Biol 2012 0.82
43 The effect of TGF-beta receptor binding peptides on smooth muscle cells. Biochem Biophys Res Commun 2002 0.82
44 Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo. Biochim Biophys Acta 2002 0.81
45 Receptor-mediated targeting of cathepsins in professional antigen presenting cells. Angew Chem Int Ed Engl 2009 0.80
46 Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis. J Immunol 2013 0.80
47 TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation. PLoS One 2013 0.80
48 Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. PLoS One 2013 0.79
49 Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice. Atherosclerosis 2012 0.79
50 IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice. Vaccine 2010 0.79
51 Complement factor C5a induces atherosclerotic plaque disruptions. J Cell Mol Med 2014 0.79
52 Leukocytosis and enhanced susceptibility to endotoxemia but not atherosclerosis in adrenalectomized APOE knockout mice. PLoS One 2013 0.78
53 Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism. PLoS One 2012 0.78
54 Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. PLoS One 2012 0.78
55 Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery disease. PLoS One 2012 0.78
56 Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012 0.78
57 Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol 2016 0.78
58 Targeted pH-dependent fluorescent activity-based cathepsin probes. Chem Commun (Camb) 2011 0.77
59 Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability. Ann Surg 2015 0.77
60 Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagul Fibrinolysis 2007 0.76
61 A multivalent ligand for the mannose-6-phosphate receptor for endolysosomal targeting of an activity-based probe. Angew Chem Int Ed Engl 2014 0.76
62 Interference of the CD30-CD30L pathway reduces atherosclerosis development. Arterioscler Thromb Vasc Biol 2012 0.76
63 Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. PLoS One 2012 0.76
64 Toll-Like Receptor induced CD11b and L-selectin response in patients with coronary artery disease. PLoS One 2013 0.75
65 Novel B-cell subsets in atherosclerosis. Curr Opin Lipidol 2016 0.75
66 A vaccine against atherosclerosis: myth or reality? Future Cardiol 2008 0.75
67 Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras. Transplantation 2009 0.75